CD79A and infection: The ability to eliminate virus or kill virus-infected cells through Fc-mediated mechanisms may explain why levels or avidity of SIV-specific IgA antibodies in serum have been correlated with control of infection against neutralization-resistant SIV in some NHP vaccine studies [17–19].